Brain gene therapy tested for Parkinson's control
NCT ID NCT05603312
Summary
This early-stage study tested the safety of a new gene therapy for Parkinson's disease. Fourteen participants with Parkinson's underwent a surgical procedure where a gene was delivered to a specific area of the brain. The goal was to see if this approach was safe and could help better control the disease's symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University Irving Medical Center
New York, New York, 10032, United States
-
Henry Ford West Bloomfield Hospital
West Bloomfield, Michigan, 48322, United States
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
-
Weill Cornell Medicine
New York, New York, 10021, United States
-
West Virginia University
Morgantown, West Virginia, 26506, United States
-
Yale University - Yale New Haven Hospital
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.